Gout Medication Use Lower Among T2DM Patients Using SGLT2 Inhibitors Tags GLP-1 agonists DPP-4 inhibitors SGLT-2 Inhibitor Read more about Gout Medication Use Lower Among T2DM Patients Using SGLT2 Inhibitors
GLP-1-Based Therapies Show Distinct CV and Renal Effects in T2DM Tags Coronary artery disease Myocardial infarction GLP-1 agonists DPP-4 inhibitors Read more about GLP-1-Based Therapies Show Distinct CV and Renal Effects in T2DM
Liraglutide 1.8 mg Shows Greater Weight Loss in T2DM Meta-analysis Tags hBA1c GLP-1 agonists Read more about Liraglutide 1.8 mg Shows Greater Weight Loss in T2DM Meta-analysis
Lower MACE Rates Seen With Tirzepatide vs Dulaglutide in T2DM Tags Coronary artery disease Myocardial infarction Stroke GLP-1 agonists Read more about Lower MACE Rates Seen With Tirzepatide vs Dulaglutide in T2DM
GLP-1 RAs Show Lower Mortality in RA With Type 2 Diabetes Tags Diabetic Nephropathy Coronary artery disease Myocardial infarction GLP-1 agonists DPP-4 inhibitors Read more about GLP-1 RAs Show Lower Mortality in RA With Type 2 Diabetes
Semaglutide Improves Insulin Sensitivity in Schizophrenia With Prediabetes Tags GLP-1 agonists Read more about Semaglutide Improves Insulin Sensitivity in Schizophrenia With Prediabetes
GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM Tags Coronary artery disease Stroke GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM
Tirzepatide Shows CV Event Reductions in T2DM Tags Coronary artery disease GLP-1 agonists Myocardial infarction Read more about Tirzepatide Shows CV Event Reductions in T2DM
GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors Tags DPP-4 inhibitors GLP-1 agonists hBA1c Read more about GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors
Dose Escalation Linked to GI Tolerance With Incretins Tags GLP-1 agonists Read more about Dose Escalation Linked to GI Tolerance With Incretins